Pharsight

Drug name - Verquvo

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10736896 MERCK SHARP DOHME Substituted 5-fluoro-1H-pyrazolopyridines and their use
May, 2031

(8 years from now)

US8420656 MERCK SHARP DOHME Substituted 5-fluoro-1H-pyrazolopyridines and their use
May, 2031

(8 years from now)

US9604948 MERCK SHARP DOHME Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Nov, 2032

(10 years from now)

CN103038232A MERCK SHARP DOHME Sgc Stimulant Single Or Combined With Pde5 Inhibitor, Use Of Sgc Activators For The Treatment Of Systemic Sclerosis (Ssc)
May, 2022

(4 months ago)

CN103038232B MERCK SHARP DOHME Sgc Stimulant Single Or Combined With Pde5 Inhibitor, Use Of Sgc Activators For The Treatment Of Systemic Sclerosis (Ssc)
May, 2022

(4 months ago)

CN102939289B MERCK SHARP DOHME Substituted 5 - -1H - Pyrazolopyridine Compound And Use Thereof
May, 2031

(8 years from now)

CN102939289A MERCK SHARP DOHME Substituted 5-Fluoro-1H-Naphthyridine Compound And Application Thereof
May, 2031

(8 years from now)

CN104159898A MERCK SHARP DOHME A Method Of Preparing Substituted 5-Fluoro -1H - Pyrazolopyridine Compound
Nov, 2032

(10 years from now)

CN104159898B MERCK SHARP DOHME A Method Of Preparing Substituted 5-Fluoro -1H - Pyrazolopyridine Compound
Nov, 2032

(10 years from now)

CN105503867A MERCK SHARP DOHME Method For Preparing Substituted 5-Fluorin--1H-Pyrromonazole Series Compound
Nov, 2032

(10 years from now)

CN105503867B MERCK SHARP DOHME A Method Of Preparing Substituted 5-Fluoro -1H - Pyrazolopyridine Compound
Nov, 2032

(10 years from now)

IN201210257P1 MERCK SHARP DOHME Substituted 5-Fluoro-1H-Pyrazolopyridines And Use Thereof
May, 2031

(8 years from now)

IN316570B MERCK SHARP DOHME Substituted 5- Fluoro-1Hpyrazolopyridines And Use Thereof
May, 2031

(8 years from now)

IN201818031789A MERCK SHARP DOHME Method For Producing Substituted 5-Fluoro-1H-Pyrazolopyridines
Nov, 2032

(10 years from now)

IN201403692P1 MERCK SHARP DOHME Method For Producing Substituted 5-Fluoro-1H-Pyrazolopyridines
Nov, 2032

(10 years from now)

IN384641B MERCK SHARP DOHME Method For Producing Substituted 5-Fluoro-1H-Pyrazolopyridines
Nov, 2032

(10 years from now)

IN303187B MERCK SHARP DOHME Method For Producing Substituted 5-Fluoro-1H-Pyrazolopyridines
Nov, 2032

(10 years from now)

EP2576548A1 MERCK SHARP DOHME The Use Of Sgc Stimulators, Sgc Activators, Alone And Combinations With Pde5 Inhibitors For The Treatment Of Systemic Sclerosis (Ssc)
May, 2031

(8 years from now)

EP2576548B1 MERCK SHARP DOHME The Use Of Sgc Stimulators, Sgc Activators, Alone And Combinations With Pde5 Inhibitors For The Treatment Of Systemic Sclerosis (Ssc)
May, 2031

(8 years from now)

EP2576547A1 MERCK SHARP DOHME Substituted 5-Fluoro-1H-Pyrazolopyridines And Use Thereof
May, 2031

(8 years from now)

EP2576547B1 MERCK SHARP DOHME Substituted 5-Fluoro-1H-Pyrazolopyridines And Use Thereof
May, 2031

(8 years from now)

EP2782914A1 MERCK SHARP DOHME Method For Producing Substituted 5-Fluoro-1H-Pyrazolopyridines
Nov, 2032

(10 years from now)

EP2896617B1 MERCK SHARP DOHME Method For Producing Substituted (Z)-Alpha-Fluoro-Beta-Amino-Acrylaldehydes
Nov, 2032

(10 years from now)

EP3421470B8 MERCK SHARP DOHME Substituted 5-Fluoro-1H-Pyrazolopyridines In Crystalline Form
Nov, 2032

(10 years from now)

EP2782914B1 MERCK SHARP DOHME Method For Producing Substituted 5-Fluoro-1H-Pyrazolopyridines
Nov, 2032

(10 years from now)

EP3421470A1 MERCK SHARP DOHME Substituted 5-Fluoro-1H-Pyrazolopyridines In Crystalline Form
Nov, 2032

(10 years from now)

EP3421470B1 MERCK SHARP DOHME Substituted 5-Fluoro-1H-Pyrazolopyridines In Crystalline Form
Nov, 2032

(10 years from now)

EP2896617A1 MERCK SHARP DOHME Method For Producing Substituted (Z)-Alpha-Fluoro-Beta-Amino-Acrylaldehydes
Nov, 2032

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9993476 MERCK SHARP DOHME Substituted 5-flouro-1H-pyrazolopyridines and their use May, 2031

(8 years from now)

US8921377 MERCK SHARP DOHME Substituted 5-fluoro-1H-pyrazolopyridines and their use May, 2031

(8 years from now)

Drugs and Companies using VERICIGUAT ingredient

Treatment: Reducing the risk of cardiovascular death and heart failure (hf) hospitalization following a hospitalization for hf or need for outpatient iv diuretics, in adults with symptomatic chronic hf and ejection fraction less than 45%

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
2.5MG TABLET;ORAL Prescription
5MG TABLET;ORAL Prescription
10MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.